Brief: Polyrizon Advances Towards Human Clinical Trials Secures First U.S. Clinical Site For Nasarix™ Allergy Blocker Clinical Trial
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM
Enters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded Warrants
U.S. STOCKS ON THE MOVE-Enovis, Cheniere, Packaging Corp of America
U.S. STOCKS ON THE MOVE-Qnity, J.M. Smucker, Vistra
Polyrizon rises as lab study shows improved nasal delivery for overdose drug
U.S. STOCKS ON THE MOVE-Target, Warner Bros Discovery , Copper miners
U.S. STOCKS ON THE MOVE-Zimmer Biomet, Datadog, Ecolab
U.S. STOCKS ON THE MOVE-Vistra Corp, Quest Diagnostics, Jacobs Solutions
Drug developer Polyrizon climbs on deal to buy 51% of air ambulance operator
Brief: Polyrizon Intends To Secure Controlling Stake In Profitable Private Jet Operator
U.S. STOCKS ON THE MOVE-SpyGlass, Agomab, Piper Sandler, Molina
U.S. STOCKS ON THE MOVE-Microchip, Under Armour, Avery Dennison
U.S. STOCKS ON THE MOVE-Biogen, Bloom Energy, Ubiquiti
Brief: Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAI
Polyrizon jumps as it teams up with Clearmind for intranasal drug delivery
Brief: Polyrizon To Buy 51% Stake In Arrow Aviation For $5.8 Million
Brief: Polyrizon Ltd To Explore Revenue-Generating Investment Opportunities In High-Growth Sectors
Brief: Polyrizon Expects Nasarix Introduction Aligned With Clinical Progress